$119.2M Contract For SARS-CoV-2 Molecular Test Production Awarded To Hologic Inc.
Hologic Inc., Marlborough, Massachusetts, has been awarded a $119,285,089 firm-fixed-price contract for SARS-CoV-2 molecular test production and capacity expansion. This contract provides for the expansion of manufacturing capabilities through additional equipment, material/supplies, and facility infrastructure. Work will be performed in Somerset, Wisconsin; Hudson, Wisconsin; Menomonie, Wisconsin; Anaheim, California; Baldwin, Wisconsin; Guilford, Maine; and San Diego, California, and is expected to be completed by January 2022. This award is the result of a competitive acquisition. Funding is authorized through Health Care Enhancement Act (H.R. 266) from the Biomedical Advanced Research and Development Authority in the full amount which is being obligated at the time of the award. The Air Force Life Cycle Management Center, Eglin Air Force Base, Florida, is the contracting activity (FA8656-21-C-0002).
Hologic, Inc. is a developer, manufacturer, and supplier of premium diagnostic products, medical imaging systems, and surgical products. The Company’s core business units focus on diagnostics, breast health, GYN surgical, and skeletal health. (www.bloomberg.com)